Cleared Traditional

K191745 - Medtronic Commander Flex

K191745 is an FDA 510(k) clearance for Medtronic Commander Flex, manufactured by Medtronic Care Management Services. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 319-day FDA review.

K191745 · Medtronic Care Management Services · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2020
Decision
319d
Days
Class 2
Risk

K191745 is an FDA 510(k) clearance for the Medtronic Commander Flex. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Medtronic Care Management Services (Chanhassan, US). The FDA issued a Cleared decision on May 15, 2020 after a review of 319 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic Care Management Services devices

FDA 510(k) Submission Details - K191745

510(k) Number K191745 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2019
Decision Date May 15, 2020
Days to Decision 319 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
194d slower than avg
Panel avg: 125d · This submission: 319d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

The Tamarack Group-Mpls, LLC
Charmaine Sutton

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 844
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K191745.
Microlife Upper Arm Automatic Digital Blood Pressure Monitor
K200297 · Microlife Intellectual Property GmbH · Jun 2020
Full Automatic(NIBP) Blood Pressure Monitor
K200521 · Health & Life Co., Ltd. · Jun 2020
Automatic Digital Blood Pressure Monitor
K190982 · Xiamen Ants Bro Technology Co., Ltd. · May 2020
BP-BT Kiosk
K200287 · Ld Technology, LLC · May 2020
Globalcare Blood Pressure Monitor
K192609 · Globalcare Medical Technology Co., Ltd. · Apr 2020
Upper Arm Blood Pressure Monitor
K191894 · Shenzhen Zhengkang Technology Co., Ltd. · Feb 2020